Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (231-240 of 349) with videos related to

Pageof 35
Sort By:
Advances in Biochemical Psychopharmacology|January 1, 1983
Brain iron and dopamine receptor functionM B Youdim, D Ben-Shachar, R Ashkenazi, et al.
Clinical Pharmacology and Therapeutics|December 1, 1994
Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline)S R Goldberg, S Yasar, J Bergman, et al.
Endocrinology|February 1, 1986
Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptorT Amit, R J Barkey, M Gavish, et al.
Ciba Foundation Symposium|January 1, 1980
Inactivation of monoamines by the lungM B Youdim, Y S Bakhle, R R Ben-Harari
Ciba Foundation Symposium|December 7, 1976
Monoamine metabolism and platelet function in iron-deficiency anaemiaH F Woods, M B Youdim, D Boullin, et al.
Advances in Neurology|September 14, 2001
Drugs to prevent cell death in Parkinson's disease. Neuroprotection against oxidative stress and inflammatory gene expressionM B Youdim, E Grünblatt, Y Levites-Royak, et al.
British Journal of Pharmacology|May 1, 1970
The promotion of phenolic alcohol formation in man by reserpine and ethanolS B Carter, F Karoum, M Sandler, et al.
Advances in Neurology|January 1, 1990
The role of iron in the basal ganglionM B Youdim, D Ben-Shachar, S Yehuda, et al.
Journal of Neurochemistry|September 1, 1994
Altered brain metabolism of iron as a cause of neurodegenerative diseases?M Gerlach, D Ben-Shachar, P Riederer, et al.
FEBS Letters|April 5, 1983
Characterization of CHAPS-solubilized prolactin receptors induced by estradiol in liver of male rats. Unmasking of cryptic sites by CHAPSM Gavish, T Amit, R J Barkey, et al.
Pageof 35

Showing results (231-240 of 349) with videos related to

Sort By:
Pageof 35
Advances in Biochemical Psychopharmacology|January 1, 1983
Brain iron and dopamine receptor functionM B Youdim, D Ben-Shachar, R Ashkenazi, et al.
Clinical Pharmacology and Therapeutics|December 1, 1994
Introduction: examination of clinical and preclinical pharmacologic data relating to abuse liability of l-deprenyl (selegiline)S R Goldberg, S Yasar, J Bergman, et al.
Endocrinology|February 1, 1986
Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptorT Amit, R J Barkey, M Gavish, et al.
Ciba Foundation Symposium|January 1, 1980
Inactivation of monoamines by the lungM B Youdim, Y S Bakhle, R R Ben-Harari
Ciba Foundation Symposium|December 7, 1976
Monoamine metabolism and platelet function in iron-deficiency anaemiaH F Woods, M B Youdim, D Boullin, et al.
Advances in Neurology|September 14, 2001
Drugs to prevent cell death in Parkinson's disease. Neuroprotection against oxidative stress and inflammatory gene expressionM B Youdim, E Grünblatt, Y Levites-Royak, et al.
British Journal of Pharmacology|May 1, 1970
The promotion of phenolic alcohol formation in man by reserpine and ethanolS B Carter, F Karoum, M Sandler, et al.
Advances in Neurology|January 1, 1990
The role of iron in the basal ganglionM B Youdim, D Ben-Shachar, S Yehuda, et al.
Journal of Neurochemistry|September 1, 1994
Altered brain metabolism of iron as a cause of neurodegenerative diseases?M Gerlach, D Ben-Shachar, P Riederer, et al.
FEBS Letters|April 5, 1983
Characterization of CHAPS-solubilized prolactin receptors induced by estradiol in liver of male rats. Unmasking of cryptic sites by CHAPSM Gavish, T Amit, R J Barkey, et al.
Pageof 35